ReviewCureus2025
Clinical Perspectives on Stroke Prevention in Patients with Non-valvular Atrial Fibrillation in the Philippines.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stroke prevention in patients with non-valvular atrial fibrillation (NVAF) is a public health priority in the Philippines. This paper aims to assess the existing gaps in stroke prevention and management for patients with NVAF in the Philippines. It focuses on identifying stroke risk, evaluating barriers to care, and ensuring treatment adherence. Barriers such as financial constraints, lack of awareness, and difficulties in accessing healthcare facilities hinder timely diagnosis and proper management. Despite the availability of stroke-ready hospitals, gaps in stroke care infrastructure, including a shortage of specialized healthcare professionals, continue to affect patient outcomes and delay intervention. To improve stroke prevention in patients with NVAF, a comprehensive strategy is needed. This approach should focus on enhancing healthcare infrastructure, expanding public and healthcare provider education, and addressing disparities in care. Furthermore, ensuring access to effective pharmacological options is essential. Non-vitamin K oral anticoagulants, which may be more suitable for resource-limited settings, offer advantages such as reduced risk of bleeding and minimal monitoring requirements. A patient-centric approach that prioritizes adherence and access to pharmacological treatments can help reduce the stroke burden and improve long-term outcomes for patients with NVAF in the Philippines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.